This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 04/28/2020
Location: Rochester, MN
Subject: Overiew of Mayo Clinic Initiatives Related to COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Media, industry, government, and other invited guests

Event Date: 04/30/2020
Location: Virtual
Subject: Medical Device Manufacturers Association Annual Meeting: Update on FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other invited guests

Event Date: 05/01/2020
Location: Teleconference
Subject: COVID-19 Update
FDA Participant/Group: N/A
Non FDA Participant/Group: David Ricks (Eli Lilly and Company);

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 04/28/2020
Location: Virtual
Subject: Clinical Trials Transformation Initiative (CTTI) Member Meeting
FDA Participant/Group: JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Patients, academics, providers and other stakeholders

Event Date: 04/29/2020
Location: Virtual
Subject: Society of Toxicology (SOT) FDA Food Safety Colloquium: Artificial Intelligence Applications in Food and Cosmetic Safety Webcast
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, industry, and other stakeholders

Event Date: 04/29/2020
Location: Virtual
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA): COVID-19 Data Sharing
FDA Participant/Group: GINA VALO; PATRIZIA CAVAZZONI; SARAH LYNCH; SHAAVHREE BUCKMAN GARNER; DAYLE CRISTINZIO; JOSEPH FRANKLIN; MIMI NGUYEN; MARY SLACK;
Non FDA Participant/Group: James Mayne, Kelly Goldberg, Lucy Vereshchagina, Mary Kosinski, Richard Moscicki (PhRMA); Dan Casserly, Eric Hughes, John Tsai, Rob Kowalski, Sharon Olmstead, Vas Narasimhan (Novartis); Carl Garner (Eli Lilly); Mathai Mammen (JNJ); Eric Olson, Levi Garoway, Levi Garraway (Genentech); JR Meloro, Peter Honig (Pfizer); Mara Guarducci, Rob Lenz (Amgen); Timothy Montague (GSK); Eddie Reilly (Sanofi); Anne Heatherington (Takeda Pharmaceutical); Annetta Beauregard (Janssen); Liz Roberts (UCB);

Event Date: 04/30/2020
Location: Virtual
Subject: Regean-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff participated or listened in
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/28/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several staff members from the U.S. Senate Committee on Health, Education, Labor, and Pensions

Event Date: 04/29/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several staff members from the U.S. House Committee on Energy and Commerce

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/30/2020
Location: Virtual
Subject: CDRH Town Hall: Medical Device Manufacturers Association (MDMA) Annual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Medical Device Manufacturers Association members

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event